Darren Schulte, MD, is Chief Innovation Officer at Centene Corporation. Prior to Centene, Darren served as CEO of Apixio, a technology company that applies AI for risk and quality measurement, which was acquired by Centene in 2020. Before joining Apixio, Darren served in executive leadership roles at Anvita Health and Resolution Health, both of which were acquired by national payers. Darren is a nationally recognized speaker on the topics of healthcare analytics and quality improvement, and he serves on the NCQA Committee for Performance Measurement. Darren received his BS degree from Berkeley, his MPP degree from Harvard, and his MD from Stanford. He is the co-inventor of 6 US patents.